检索结果 - Miso Kim

Refine Results
  1. 1
    The Korea National Disability Registration System

    The Korea National Disability Registration System 由 Miso Kim, Wonyoung Jung, So Young Kim, Jong Hyock Park, Dong Wook Shin

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    HLA‐B27 association of autoimmune encephalitis induced by PD‐L1 inhibitor

    HLA‐B27 association of autoimmune encephalitis induced by PD‐L1 inhibitor 由 Hyeyeon Chang, Yong‐Won Shin, Bhumsuk Keam, Miso Kim, Seock‐Ah Im, Soon‐Tae Lee

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Laminar Flow Activation of ERK5 Protein in Vascular Endothelium Leads to Atheroprotective Effect via NF-E2-related Factor 2 (Nrf2) Activation

    Laminar Flow Activation of ERK5 Protein in Vascular Endothelium Leads to Atheroprotective Effect via NF-E2-related Factor 2 (Nrf2) Activation 由 Miso Kim, Suji Kim, Jae Hyang Lim, Chu Hee Lee, Hyoung Chul Choi, Chang Hoon Woo

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer

    Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer 由 Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib

    Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib 由 Seulki Kim, Tae Min Kim, Dong‐Wan Kim, Soyeon Kim, Miso Kim, Yong‐Oon Ahn, Bhumsuk Keam, Dae Seog Heo

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients

    Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis... 由 Yeonjoo Choi, Bhumsuk Keam, Miso Kim, Shinkyo Yoon, Dalyong Kim, Jong Gwon Choi, Ja Young Seo, Inkeun Park, Jae‐Lyun Lee

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

    The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis 由 Ryul Kim, Seokyung Hahn, Junghoon Shin, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma

    Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma 由 Seong-Ho Kang, Bhumsuk Keam, Yong‐Oon Ahn, Ha-Ram Park, Miso Kim, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma

    A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma 由 Miso Kim, Tae‐Min Kim, Bhumsuk Keam, Yu Jung Kim, Jin Chul Paeng, Kyung Chul Moon, Dong‐Wan Kim, Dae Seog Heo

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicity

    Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicity 由 Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Se Hyun Kim, Yu Jung Kim, Tae Min Kim, Dong‐Wan Kim, Jong Seok Lee, Dae Seog Heo

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines

    Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines 由 Ji‐Eun Park, Seong‐Eun Kim, Bhumsuk Keam, Ha-Ram Park, Soyeon Kim, Miso Kim, Tae Min Kim, Junsang Doh, Dong‐Wan Kim, Dae Seog Heo

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration

    Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration 由 Chan-Young Ock, Bhumsuk Keam, Sehui Kim, Ju–Seog Lee, Miso Kim, Tae Min Kim, Yoon Kyung Jeon, Dong‐Wan Kim, Doo Hyun Chung, Dae Seog Heo

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer

    Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer 由 Soo-Min Kim, Jaemoon Koh, Tae Min Kim, Songji Oh, Soyeon Kim, Jeonghwan Youk, Miso Kim, Bhumsuk Keam, Yoon Kyung Jeon, Dong‐Wan Kim, Dae Seog Heo

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer

    Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer 由 Sehui Kim, Ji-Young Jang, Jaemoon Koh, Dohee Kwon, Young A Kim, Jin Chul Paeng, Chan‐Young Ock, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dae Seog Heo, Doo Hyun Chung, Yoon Kyung Jeon

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors

    Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors 由 Ryul Kim, Bhumsuk Keam, Sehui Kim, Miso Kim, Se Hyun Kim, Jin‐Wook Kim, Yu Jung Kim, Tae Min Kim, Yoon Kyung Jeon, Dong‐Wan Kim, Doo Hyun Chung, Jong Seok Lee, Dae Seog Heo

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real‐world data (KCSG LU20‐11)

    Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after... 由 Hong-Sik Kim, Dong‐Wan Kim, Miso Kim, Youngjoo Lee, Hee Kyung Ahn, Jang Ho Cho, Il Hwan Kim, Yun‐Gyoo Lee, Seong Hoon Shin, Song Ee Park, Ji Yoon Jung, Eun Joo Kang, Myung‐Ju Ahn

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma

    PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma 由 Chan-Young Ock, Sehui Kim, Bhumsuk Keam, Miso Kim, Tae Min Kim, Jin-Ho Kim, Yoon Kyung Jeon, Ju–Seog Lee, Seong Keun Kwon, J. Hun Hah, Tack‐Kyun Kwon, Dong‐Wan Kim, Hong-Gyun Wu, Myung‐Whun Sung, Dae Seog Heo

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma

    Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma 由 Changhee Park, Kwon Joong Na, Hongyoon Choi, Chan‐Young Ock, Seunggyun Ha, Miso Kim, Samina Park, Bhumsuk Keam, Tae Min Kim, Jin Chul Paeng, In Kyu Park, Chang Hyun Kang, Dong‐Wan Kim, Gi Jeong Cheon, Keon Wook Kang, Young Tae Kim, Dae Seog Heo

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study

    Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study 由 William K. Kelly, Daniel C. Danila, Chia‐Chi Lin, Jae‐Lyun Lee, Nobuaki Matsubara, Patrick J. Ward, Andrew J. Armstrong, David Pook, Miso Kim, Tanya B. Dorff, Stefanie Fischer, Yung‐Chang Lin, Lisa G. Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M. Smith, Jamie N. Connarn, Hweixian Leong Penny, Julia Stieglmaier, Leonard J. Appleman

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

    Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma 由 Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E. Hutson, Evgeny Kopyltsov, María José Méndez-Vidal, Vadim Kozlov, Anna Alyasova, Sung‐Hoo Hong, Anil Kapoor, Teresa Alonso Gordoa, Jaime R. Merchan, Eric Winquist, Pablo Maroto, Jeffrey C. Goh, Miso Kim, Howard Gurney, Vijay Patel, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Bohuslav Melichar, Frédéric Rolland, Ugo De Giorgi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Corina E. Dutcus, Alan D. Smith, Lea Dutta, Kalgi Mody, Rodolfo F. Perini, Dongyuan Xing, Toni K. Choueiri

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: